Haploinsufficiency of TNXB Is Associated with Hypermobility Type of Ehlers-Danlos Syndrome
Open accessThe DOI matches its Crossref record; 14 of the 16 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Interestingly, there have also been reports of heterozygous TNXB gene mutations causing tenascin-X haploinsufficiency, which also results in the signs and symptoms of hypermobile-type EDS [14, 19, 20].”
From Salt-wasting congenital adrenal hyperplasia phenotype as a result of the TNXA/TNXB chimera 1 (CAH-X CH-1) and the pathogenic IVS2-13A/C > G in CYP21A2 gene (2023) · cites this paper as [20]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Family members with a haploinsufficient mutation in the TNXB gene have been described to have symptoms of joint hypermobility in 60% of the cases, but more research is needed to confirm this [Zweers et al., 2003].”
From The Ehlers–Danlos syndromes, rare types (2017) · cites this paper as Zweers et al., 2003
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Many patients with congenital adrenal hyperplasia (CAH) due to 21-hydroxylase de fi ciency have CAH-X syndrome, a connective tissue dysplasia consistent with hypermobility-type Ehlers-Danlos syndrome due to a contiguous gene deletion involving the adjacent CYP21A2 and TNXB genes.”
From High-Throughput Screening for CYP21A1P-TNXA/TNXB Chimeric Genes Responsible for Ehlers Danlos Syndrome in Patients with Congenital Adrenal Hyperplasia. (2019) · cites this paper as [10]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The serum tenascin-X test based on enzyme-linked immunosorbent assay has been used to identify complete de fi ciency, but it is not accurate in identifying heterozygous forms and is not commercially available for general practice. 9,10”
From High-Throughput Screening for CYP21A1P-TNXA/TNXB Chimeric Genes Responsible for Ehlers Danlos Syndrome in Patients with Congenital Adrenal Hyperplasia. (2019) · cites this paper as [10]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The authors concluded that TNXB haploinsufficiency is associated with hEDS [Zweers et al., 2003].”
From The Ehlers–Danlos syndromes, rare types (2017) · cites this paper as Zweers et al., 2003
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Articular mobility in an African population.
Beighton, P., Solomon, L., & Soskolne, C. L. (1973) · Annals of the Rheumatic Diseases · doi:10.1136/ard.32.5.413 · Cited by 1,727
Connective Tissue and Its Heritable Disorders: Molecular, Genetic, and Medical Aspects
(2002) · Wiley eBooks · doi:10.1002/0471221929 · Cited by 949
(2000) · PubMed · Cited by 738
A recessive form of the Ehlers-Danlos syndrome caused by tenascin-X deficiency
Schalkwijk, J., Zweers, M. C., Steijlen, P. M., Dean, W. B., Taylor, G., van Vlijmen, I. M., van Haren, B., Miller, W. L., & Bristow, J. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa002939 · Cited by 391
Self-citationTenascin-X deficiency is associated with Ehlers-Danlos syndrome
Burch, G. H., Gong, Y., Liu, W., Dettman, R. W., Curry, C. J., Smith, L., Miller, W. L., & Bristow, J. (1997) · Nature Genetics · doi:10.1038/ng0997-104 · Cited by 366
Self-citationSteinmann, B., Royce, P. M., & Superti‐Furga, A. (2002) · Connective Tissue and Its Heritable Disorders · doi:10.1002/0471221929.ch9 · Cited by 358
Joint hypermobility and genetic collagen disorders: are they related?
Grahame, R. (1999) · Archives of Disease in Childhood · doi:10.1136/adc.80.2.188 · Cited by 344
Mao, J. R., Taylor, G., Dean, W. B., Wagner, D. R., Afzal, V., Lotz, J. C., Rubin, E. M., & Bristow, J. (2002) · Nature Genetics · doi:10.1038/ng850 · Cited by 261
Self-citationHypermobility: features and differential incidence between the sexes
Larsson, L., Baum, J., & Mudholkar, G. S. (1987) · Arthritis & Rheumatism · doi:10.1002/art.1780301216 · Cited by 245
Byers, P. H. (1994) · Journal of Investigative Dermatology · doi:10.1038/jid.1994.9 · Cited by 128
Cited by
Tinkle, B., Castori, M., Berglund, B., Cohen, H., Grahame, R., Kazkaz, H., & Levy, H. (2017) · American Journal of Medical Genetics Part C: Seminars in Medical Genetics · doi:10.1002/ajmg.c.31538 · Cited by 499
“The region contains several pseudogenes including those for TNXB and CYP21A2.”
BackgroundInfluentialThe Ehlers–Danlos syndrome, a disorder with many faces
De Paepe, A., & Malfait, F. (2012) · Clinical Genetics · doi:10.1111/j.1399-0004.2012.01858.x · Cited by 379
“have showed that a subset of patients with EDS-HT or JHS presents haploinsufficiency for tenascin-X (38), an ECM molecule already linked to an AR form of EDS resembling classic EDS (see above).”
Ehlers-Danlos syndrome type IV
Germain, D. P. (2007) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-2-32 · Cited by 376
Malfait, F., Castori, M., Francomano, C. A., Giunta, C., Kosho, T., & Byers, P. H. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-0194-9 · Cited by 316
Clinical and genetic aspects of Ehlers-Danlos syndrome, classic type
Malfait, F., Wenstrup, R. J., & De Paepe, A. (2010) · Genetics in Medicine · doi:10.1097/gim.0b013e3181eed412 · Cited by 293
Ehlers-Danlos syndromes and Marfan syndrome
Callewaert, B., Malfait, F., Loeys, B., & De Paepe, A. (2008) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2007.12.005 · Cited by 257
The Ehlers–Danlos syndromes, rare types
Brady, A. F., Demirdas, S., Fournel‐Gigleux, S., Ghali, N., Giunta, C., Kapferer‐Seebacher, I., Kosho, T., Mendoza‐Londono, R., Pope, M. F., Rohrbach, M., et al. (2017) · American Journal of Medical Genetics Part C Seminars in Medical Genetics · doi:10.1002/ajmg.c.31550 · Cited by 258
“Family members with a haploinsufficient mutation in the TNXB gene have been described to have symptoms of joint hypermobility in 60% of the cases, but more research is needed to confirm this [Zweers et al., 2003].”
BackgroundResultCastori, M., Camerota, F., Celletti, C., Danese, C., Santilli, V., Saraceni, V. M., & Grammatico, P. (2010) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.33231 · Cited by 228
“Although tenascin-X monoallelic or biallelic inactivation is claimed as responsible for HT-EDS, mutations in this gene can be documented in no more than 10% of the patients [Schalkwijk et al., 2001; Zweers et al., 2003].”
BackgroundCastori, M. (2012) · ISRN Dermatology · doi:10.5402/2012/751768 · Cited by 222
“Known for decades as a hereditary condition with predominant rheumatologic manifestations, it is now emerging as a multisystemic disorder with widespread manifestations.”
BackgroundTendon and ligament: Development, repair and disease
Tozer, S., & Duprez, D. (2005) · Birth Defects Research Part C: Embryo Today: Reviews · doi:10.1002/bdrc.20049 · Cited by 187
The genetic basis of the joint hypermobility syndromes
Malfait, F., Hakim, A. J., De Paepe, A., & Grahame, R. (2006) · Rheumatology · doi:10.1093/rheumatology/kei268 · Cited by 171
“However, haploinsufficiency of tenascin-X can account for only a small subset of patients with joint hypermobility, as it was detected in only 5–10% of series of patients with EDS, hypermobility type, or JHS [17].”
BackgroundInfluentialNeuromuscular involvement in various types of Ehlers–Danlos syndrome
Voermans, N. C., van Alfen, N., Pillen, S., Lammens, M., Schalkwijk, J., Zwarts, M. J., van Rooij, I. A., Hamel, B. C. J., & van Engelen, B. G. (2009) · Annals of Neurology · doi:10.1002/ana.21643 · Cited by 168
“Four of the first-grade family members of the TNX-deficient type EDS patients had been diagnosed with hypermobility type EDS; the other six subjects had not been diagnosed with the hypermobility type so far but did show one or more of the clinical features of the hypermobility type of EDS.1,5 TNX in serum was always f…”
BackgroundMethodInfluentialSelf-citationGensemer, C., Burks, R., Kautz, S. A., Judge, D. P., Lavallee, M. E., & Norris, R. A. (2020) · Developmental Dynamics · doi:10.1002/dvdy.220 · Cited by 182
“It is likely that this only represents a small group of patients with hEDS.(234) Interestingly, in a small study, there was evidence to indicate that some hEDS/JHS patients may have reduced serum TNX concentration compared to healthy controls, without any discernible mutations in TNXB.”
BackgroundMalfait, F., Coucke, P., Symoens, S., Loeys, B., Nuytinck, L., & De Paepe, A. (2005) · Human Mutation · doi:10.1002/humu.20107 · Cited by 136
“More recently, it was shown that haploinsufficiency of TNXB is associated with the hypermobility type of EDS [Zweers et al., 2003].”
BackgroundTenascin-X: beyond the architectural function
Valcourt, U., Alcaraz, L. B., Exposito, J.-Y., Lethias, C., & Bartholin, L. (2015) · Cell Adhesion & Migration · doi:10.4161/19336918.2014.994893 · Cited by 132
“An ultrastructural analysis of skin from TN-X-deficient patients and mice revealed that the morphology of collagen fibrils was regular,47,54 in contrast to the irregular shapes of collagen fibrils observed in the classic and hypermobility forms of EDS.55 The most striking feature was an increased distance between fibr…”
BackgroundRombaut, L., Malfait, F., De Wandele, I., Taes, Y., Thijs, Y., De Paepe, A., & Calders, P. (2012) · Arthritis Care & Research · doi:10.1002/acr.21726 · Cited by 130
“However, haploinsufficiency of TN-X has been identified only in a minority (5%) of patients with EDS-HT (11).”
BackgroundCastori, M., Camerota, F., Celletti, C., Grammatico, P., & Padua, L. (2010) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.33585 · Cited by 127
“The molecular bases of JH and EDS-HT are still largely obscure, although approximately 5% of EDS-HT patients harbor homozygous or heterozygous mutations in the TNXB gene [Schalkwijk et al., 2001; Zweers et al., 2003].”
BackgroundColombi, M., Dordoni, C., Chiarelli, N., & Ritelli, M. (2015) · American Journal of Medical Genetics Part C: Seminars in Medical Genetics · doi:10.1002/ajmg.c.31429 · Cited by 127
“The patients with the 30 kb deletion in homozygosity [Burch et al., 1997], or in compound heterozygosity with a second CYP21A2mutation [Mercke et al., 2013], also present with congenital adrenal hyperplasia (CAH).”
BackgroundInfluentialEhlers-Danlos Syndrome: Insights on Obstetric Aspects
Volkov, N., Nisenblat, V., Ohel, G., & Gonen, R. (2006) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000251027.32142.63 · Cited by 128
“Specifically, researchers believe that tenascin-X is involved in the assembly of collagen fibrils and elastic fibers, which provide structure, strength, and flexibility to connective tissue throughout the body (5).”
BackgroundKucharik, A. H., & Chang, C. (2020) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-019-08755-8 · Cited by 122
Malfait, F., Symoens, S., Coucke, P., Nunes, L., De Almeida, S., & De Paepe, A. (2006) · Journal of Medical Genetics · doi:10.1136/jmg.2005.038224 · Cited by 124
Tenascin‐X, collagen, elastin, and the Ehlers–Danlos syndrome
Bristow, J. D., Carey, W. A., Egging, D. F., & Schalkwijk, J. (2005) · American Journal of Medical Genetics Part C Seminars in Medical Genetics · doi:10.1002/ajmg.c.30071 · Cited by 135
“isolated joint hypermobility, representing nearly two-thirds of heterozygous women in the families [27].”
BackgroundSelf-citationMalfait, F., & Paepe, A. D. (2013) · Advances in experimental medicine and biology · doi:10.1007/978-94-007-7893-1_9 · Cited by 135
Bravo, J. F., & Wolff, C. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21557 · Cited by 138
“Recurrent tendinitis 12 (19) 121 (53) 4 (22) 0.”
Ehlers–Danlos syndrome: how to diagnose and when to perform genetic tests
Sobey, G. (2015) · Archives of Disease in Childhood · doi:10.1136/archdischild-2013-304822 · Cited by 98
Muscarinic acetylcholine receptor autoantibodies in patients with Sjögren's syndrome
Naito, Y., Matsumoto, I., Wakamatsu, E., Goto, D., Sugiyama, T., Matsumura, R., Ito, S., Tsutsumi, A., & Sumida, T. (2005) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2004.025478 · Cited by 99
Ehlers-Danlos Syndrome in Orthopaedics: Etiology, Diagnosis, and Treatment Implications
Shirley, E. D., DeMaio, M., & Bodurtha, J. N. (2012) · Sports Health A Multidisciplinary Approach · doi:10.1177/1941738112452385 · Cited by 107
Joint hypermobility syndromes: The pathophysiologic role of tenascin‐X gene defects
Zweers, M. C., Hakim, A. J., Grahame, R., & Schalkwijk, J. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20488 · Cited by 91
Self-citationDisorders of Connective Tissue
Burrows, N., & Lovell, C. R. (2004) · Wiley eBooks · doi:10.1002/9780470750520.ch46 · Cited by 94
Clinical heterogeneity in patients with the hypermobility type of Ehlers-Danlos Syndrome
De Wandele, I., Rombaut, L., Malfait, F., De Backer, T., De Paepe, A., & Calders, P. (2013) · Research in Developmental Disabilities · doi:10.1016/j.ridd.2012.11.018 · Cited by 89
Clinical and molecular overlap between myopathies and inherited connective tissue diseases
Voermans, N. C., Bönnemann, C. G., Huijing, P. A., Hamel, B. C. J., Kuppevelt, T. H. V., HAAN, A. D., Schalkwijk, J., van Engelen, B. G. M., & Jenniskens, G. J. (2008) · Neuromuscular Disorders · doi:10.1016/j.nmd.2008.05.017 · Cited by 96
“Haploinsufficiency of the tenascin-X gene causes hypermobility type EDS in only a minority of patients [70].”
BackgroundSelf-citationThe human gene connectome as a map of short cuts for morbid allele discovery
Itan, Y., Zhang, S., Vogt, G., Abhyankar, A., Casadio, M., Nitschké, P., Fried, D., Quintana‐Murci, L., Abel, L., & Casanova, J. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1218167110 · Cited by 97
Sinibaldi, L., Ursini, G., & Castori, M. (2015) · American Journal of Medical Genetics Part C: Seminars in Medical Genetics · doi:10.1002/ajmg.c.31430 · Cited by 87
“…an ECM glycoprotein involved in the organization and maintenance of the connective tissue structure [Petersen and Douglas, 2013], has been linked to both autosomal dominant and autosomal recessive EDS [Burch et al., 1997; Schalkwijk et al., 2001; Zweers et al., 2003, 2005; Voermans et al., 2009].”
BackgroundSabatelli, P., Gualandi, F., Gara, S. K., Grumati, P., Zamparelli, A., Martoni, E., Pellegrini, C., Merlini, L., Ferlini, A., Bonaldo, P., et al. (2011) · Matrix Biology · doi:10.1016/j.matbio.2011.12.003 · Cited by 84
Merke, D. P., Chen, W., Morissette, R., Xu, Z., Van Ryzin, C., Sachdev, V., Hannoush, H., Shanbhag, S. M., Acevedo, A. T., Nishitani, M., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-3148 · Cited by 82
TNXB Mutations Can Cause Vesicoureteral Reflux
Gbadegesin, R. A., Brophy, P. D., Adeyemo, A., Hall, G., Gupta, I. R., Hains, D., Bartkowiak, B., Rabinovich, C. E., Chandrasekharappa, S., Homstad, A., et al. (2013) · Journal of the American Society of Nephrology · doi:10.1681/asn.2012121148 · Cited by 72
Celletti, C., Castori, M., La Torre, G., & Camerota, F. (2013) · BioMed Research International · doi:10.1155/2013/580460 · Cited by 81
Infantile hypertrophic pyloric stenosis—genetics and syndromes
Peeters, B., Benninga, M. A., & Hennekam, R. C. M. (2012) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2012.133 · Cited by 74
Ehlers–Danlos syndrome: A showcase of conditions that lead to understanding matrix biology
Byers, P. H., & Murray, M. L. (2014) · Matrix Biology · doi:10.1016/j.matbio.2013.07.005 · Cited by 68
“Indeed, about 65% of carrier women had significant joint hypermobility (Zweers et al., 2003), but wider”
BackgroundInfluentialAsthma and airways collapse in two heritable disorders of connective tissue
Morgan, A. W., Pearson, S. B., Davies, S., Gooi, H. C., & Bird, H. A. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.062224 · Cited by 68
Broadening the Spectrum of Ehlers Danlos Syndrome in Patients With Congenital Adrenal Hyperplasia
Morissette, R., Chen, W., Perritt, A. F., Dreiling, J. L., Arai, A. E., Sachdev, V., Hannoush, H., Mallappa, A., Xu, Z., McDonnell, N. B., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-2232 · Cited by 68
“While autosomal recessive complete TNX deficiency is a cause of classical EDS (OMIM 130 000), (6) TNXB haploinsufficiency is associated with hypermobile EDS (OMIM 130 020), (7) and when present in patients with CAH, results in a contiguous gene deletion syndrome termed CAH-X (8).”
BackgroundTenascin‐X deficiency in autosomal recessive Ehlers–Danlos syndrome
Lindor, N. M., & Bristow, J. (2005) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.30671 · Cited by 67
“Zweers et al. examined 20 heterozygous family members [Zweers et al., 2003].”
BackgroundSelf-citationAubry-Rozier, B., Schwitzguebel, A., Valerio, F., Tanniger, J., Paquier, C., Berna, C., Hügle, T., & Benaim, C. (2021) · Rheumatology International · doi:10.1007/s00296-021-04968-3 · Cited by 66
“Despite a probable autosomal dominant inheritance [11] and reports of haploinsufficiency or missense of tenascin X in a few cases [12, 13], no gene has been identified for hEDS [11, 14].”
BackgroundSymoens, S., Malfait, F., Renard, M., André, J., Haußer, I., Loeys, B., Coucke, P. J., & Paepe, A. D. (2008) · Human Mutation · doi:10.1002/humu.20887 · Cited by 66
Interactions of human tenascin-X domains with dermal extracellular matrix molecules
Egging, D. F., van den Berkmortel, F., Taylor, G. D., Bristow, J., & Schalkwijk, J. (2006) · Archives of Dermatological Research · doi:10.1007/s00403-006-0706-9 · Cited by 70
“The skin of TNX deWcient patients is markedly lax with poor recoil properties and shows easy bruising [2, 14, 20, 22, 27 ].”
BackgroundSelf-citationEgging, D., van Vlijmen-Willems, I., van Tongeren, T., Schalkwijk, J., & Peeters, A. (2007) · Connective Tissue Research · doi:10.1080/03008200601166160 · Cited by 63
Self-citationTenascin-X, Congenital Adrenal Hyperplasia, and the CAH-X Syndrome
Miller, W. L., & Merke, D. P. (2018) · Hormone Research in Paediatrics · doi:10.1159/000481911 · Cited by 61
Gharbiya, M., Moramarco, A., Castori, M., Parisi, F., Celletti, C., Marenco, M., Mariani, I., Grammatico, P., & Camerota, F. (2012) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2012.03.023 · Cited by 70
Ghali, N., Sobey, G. J., & Burrows, N. (2019) · BMJ · doi:10.1136/bmj.l4966 · Cited by 68
Baronio, F., Ortolano, R., Menabò, S., Cassio, A., Baldazzi, L., Natale, V. D., Tonti, G., Vestrucci, B., & Balsamo, A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20184605 · Cited by 60
“may be associated with the mild “hypermobility type” of EDS [72].”
BackgroundInfluentialZweers, M., Dean, W., Van Kuppevelt, T., Bristow, J., & Schalkwijk, J. (2005) · Clinical Genetics · doi:10.1111/j.1399-0004.2005.00401.x · Cited by 58
“Our study population consisted of 16 hypermobility type EDS patients with normal TNX serum levels as determined by enzyme-linked immunosorbent assay (7), who were recruited through the Dutch EDS patient organization and in whom diagnosis was made by a medical specialist; eight TNX-haploinsufficient hypermobility type…”
BackgroundMethodInfluentialSelf-citationZweers, M. C., Kucharekova, M., & Schalkwijk, J. (2005) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2004.026559 · Cited by 65
Self-citationHeritable Collagen Disorders: The Paradigm of the Ehlers—Danlos Syndrome
Byers, P. H., & Murray, M. L. (2012) · Journal of Investigative Dermatology · doi:10.1038/skinbio.2012.3 · Cited by 63
“Indeed, obligate heterozygotes demonstrated that about 80% of carrier women but only 20% of carrier men had significant joint hypermobility (Zweers et al., 2003) but wider screening failed to document mutations at sufficient frequency to account for EDS type III.”
BackgroundPain in hypermobile Ehlers‐Danlos syndrome: New insights using new criteria
Bénistan, K., & Martinez, V. (2019) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.61175 · Cited by 53
Demirdas, S., Dulfer, E., Robert, L., Kempers, M., van Beek, D., Micha, D., van Engelen, B. G., Hamel, B., Schalkwijk, J., Loeys, B., et al. (2017) · Clinical Genetics · doi:10.1111/cge.12853 · Cited by 60
“In a previous study, haploinsufficiency of TNX was also shown to associate with hypermobility symptoms in relatives of patients with TNX-deficiency (16).”
BackgroundInfluentialSelf-citationThe Adrenal Cortex and its Disorders
Miller, W. L. (2009) · Brook's Clinical Pediatric Endocrinology · doi:10.1002/9781444316728.ch13 · Cited by 50
Voermans, N. C., Jenniskens, G. J., Hamel, B. C., Schalkwijk, J., Guicheney, P., & van Engelen, B. G. (2007) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.31899 · Cited by 49
Self-citationTenascin-X increases the stiffness of collagen gels without affecting fibrillogenesis
Margaron, Y., Bostan, L. E., Exposito, J., Malbouyres, M., Trunfio-Sfarghiu, A.-M., Berthier, Y., & Lethias, C. (2010) · Biophysical Chemistry · doi:10.1016/j.bpc.2009.12.011 · Cited by 57
“The dose–response effect that we observed might be of significant importance in vivo since in humans, different phenotypes (classical Ehlers-Danlos Syndrome versus joint hypermobility only) are observed in patients homozygous or hetereozygous for TNX mutations, indicating a gene–dosage effect [18].”
BackgroundNeurologic manifestations of inherited disorders of connective tissue
Debette, S., & Germain, D. P. (2013) · Handbook of clinical neurology · doi:10.1016/b978-0-7020-4086-3.00037-0 · Cited by 45
Tenascins and their implications in diseases and tissue mechanics
Brellier, F., Tucker, R. P., & Chiquet‐Ehrismann, R. (2009) · Scandinavian Journal of Medicine and Science in Sports · doi:10.1111/j.1600-0838.2009.00916.x · Cited by 53
“However, individuals heterozygous for TNX can also harbor mild phenotypes: alteration of a single TNX allele reduces the level of tenascin-X in serum by 50% and triggers, in some cases, a generalized joint hypermobility (Zweers et al., 2003).”
BackgroundPetersen, J. W., & Douglas, J. Y. (2013) · Medical Hypotheses · doi:10.1016/j.mehy.2013.06.005 · Cited by 44
“Subsequently, researchers conducted studies of both TNXBdeficient mice [23,26] and of human populations diagnosed with EDS-HT who displayed serum levels of TNX 50% below those of healthy patients [6,27].”
BackgroundPatients with Ehlers Danlos syndrome and CRPS: A possible association?
Stoler, J. M., & Oaklander, A. L. (2006) · Pain · doi:10.1016/j.pain.2006.02.022 · Cited by 44
“Mutations in two genes have been found in a few cases, COL3A1 (responsible for type III collagen) (Narcisi et al., 1994) and Tenascin-XB (Zweers et al., 2003).”
BackgroundThe extracellular matrix glycoprotein tenascin‐X regulates peripheral sensory and motor neurones
Aktar, R., Peiris, M., Fikree, A., Cibert‐Goton, V., Walmsley, M., Tough, I. R., Watanabe, P. D. S., Araújo, E. J. D. A., Mohammed, S. D., Delalande, J., et al. (2018) · The Journal of Physiology · doi:10.1113/jp276300 · Cited by 50
Cattalini, M., Khubchandani, R., & Cimaz, R. (2015) · Pediatric Rheumatology · doi:10.1186/s12969-015-0039-3 · Cited by 41
“TNX-B, encoding for Tenascin X, in approximately 5 % of patients with the hypermobility type, while vascular EDS is caused by heterozygous mutations in the COL3A1 gene, encoding type III collagen [23, 24].”
BackgroundSyndrome d’Ehlers-Danlos vasculaire
Perdu, J., Boutouyrie, P., Lahlou‐Laforêt, K., Kien, P. K. V., Denarié, N., Mousseaux, É., Sapoval, M. R., Julia, P. L., Zinzindohoué, F., Touraine, P. A., et al. (2006) · La Presse Médicale · doi:10.1016/s0755-4982(06)74919-3 · Cited by 47
Recurrent neuropathy associated with Ehlers–Danlos syndrome
Voermans, N. C., Drost, G., van Kampen, A., Gabreëls‐Festen, A. A. W. M., Lammens, M. M. Y., Hamel, B. C. J., Schalkwijk, J., & van Engelen, B. G. M. (2005) · Journal of Neurology · doi:10.1007/s00415-005-0056-0 · Cited by 39
“EDS is associated with deficiency of extracellular-matrix proteins such as collagen I, III and V and tenascinX, but in the hypermobility type the protein deficiency is in most cases unknown [2, 8, 10].”
BackgroundSelf-citationEhlers-Danlos syndrome, hypermobility type
INSERM (2020) · Definitions · doi:10.32388/0ekfj6 · Cited by 39
“The few described individuals with EDS, hypermobility type resulting from haploinsufficiency of tenascin X lacked easy bruisability and mildly hyperextensible skin [Zweers et al 2003].”
BackgroundGenes and Pseudogenes: Complexity of the RCCX Locus and Disease
Carrozza, C., Foca, L., De Paolis, E., & Concolino, P. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.709758 · Cited by 37
“A serum tenascin-X test, based on enzyme-linked immunosorbent assay, has been developed to identify complete deficiency, but it is not accurate in identifying heterozygous forms (69, 81).”
BackgroundTenascin-X deficiency and Ehlers-Danlos syndrome: a case report and review of the literature
O’Connell, M., Burrows, N., Vlijmen-Willems, M. J. J. V., Clark, S. M., & Schalkwijk, J. (2010) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2010.09949.x · Cited by 40
Self-citationReduced quantitative muscle function in tenascin-X deficient Ehlers-Danlos patients
Voermans, N. C., Altenburg, T. M., Hamel, B. C., de Haan, A., & van Engelen, B. G. (2007) · Neuromuscular Disorders · doi:10.1016/j.nmd.2007.04.004 · Cited by 36
“A 22-year-old woman with EDS of the hypermobility type with reduced TNX serum levels [4] had suffered from muscle hypotonia since infancy.”
BackgroundSelf-citationUpdates in Clinical and Genetics Aspects of Hypermobile Ehlers Danlos Syndrome
Forghani, I. (2018) · Balkan Medical Journal · doi:10.4274/balkanmedj.2018.1113 · Cited by 40
“Despite this reduction in serum tenascin levels, none of the heterozygous males presented with JH (29).”
BackgroundGardiner, P. V., Bell, A. L., Taggart, A. J., Wright, G., Kee, F., Smyth, A., McKane, R., Lee, J., Rooney, M. E., & Whitehead, E. (2005) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2004.025015 · Cited by 35
Rashed, E. R., Ruiz Maya, T., Black, J., Fettig, V., Kadian-Dodov, D., Olin, J. W., Mehta, L., Gelb, B. D., & Kontorovich, A. R. (2022) · Vascular Medicine · doi:10.1177/1358863x211067566 · Cited by 34
Syx, D., Symoens, S., Steyaert, W., De Paepe, A., Coucke, P. J., & Malfait, F. (2015) · Disease Markers · doi:10.1155/2015/828970 · Cited by 34
“Joint hypermobility often appears as a familial trait and is shared by several heritable connective tissue disorders, including the hypermobility subtype of the Ehlers-Danlos syndrome (EDSHT) or benign joint hypermobility syndrome (BJHS).”
BackgroundInfluentialDermal connective tissue development in mice: an essential role for tenascin-X
Egging, D. F., van Vlijmen, I., STARCHER, B. C., Gijssen, Y., Zweers, M. C., Blankevoort, L., Bristow, J., & Schalkwijk, J. (2005) · Cell and Tissue Research · doi:10.1007/s00441-005-0100-5 · Cited by 42
“We conclude that TNX knockout mice only partially recapitulate the phenotype of TNX-deficient EDS patients, and that TNX could potentially be involved in maturation and/or maintenance of the dermal collagen and elastin network.”
BackgroundInfluentialSelf-citationChan, A. O. K., But, W. M., Ng, K. L., Wong, L. M., Lam, Y. Y., Tiu, S. C., Lee, K. F., Lee, C. Y., Loung, P. Y., Berry, I. R., et al. (2011) · Steroids · doi:10.1016/j.steroids.2011.04.010 · Cited by 32
Chen, W., Kim, M. S., Shanbhag, S., Arai, A., VanRyzin, C., McDonnell, N. B., & Merke, D. P. (2009) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.33092 · Cited by 32
“TNX deficiency, in recessive or dominant form, has been proposed as a cause of hypermobility type Ehlers–Danlos syndrome (EDS) [Schalkwijk et al., 2001; Zweers et al., 2003].”
BackgroundInfluentialHauptmann, G., & Bahram, S. (2004) · Current Opinion in Immunology · doi:10.1016/j.coi.2004.07.001 · Cited by 42
Gao, Y., Lu, L., Yu, B., Mao, J., Wang, X., Nie, M., & Wu, X. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa199 · Cited by 31
Matricellular Proteins: Functional Insights From Non-mammalian Animal Models
Adams, J. C. (2018) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/bs.ctdb.2018.02.003 · Cited by 34
Joint Hypermobility and Headache: Understanding the Glue That Binds the Two Together – Part 1
Neilson, D., & Martin, V. T. (2014) · Headache: The Journal of Head and Face Pain · doi:10.1111/head.12418 · Cited by 31
“Two diagnostic systems have been developed to identify patients with EDS-HT.”
BackgroundInfluentialVesicoureteral reflux and the extracellular matrix connection
Tokhmafshan, F., Brophy, P. D., Gbadegesin, R. A., & Gupta, I. R. (2017) · Pediatric Nephrology · doi:10.1007/s00467-016-3386-5 · Cited by 30
“While the major fibrillary collagens (i.e., type I, III, and V) have been ruled out as candidate genes by linkage studies, a subset of patients with HT- EDS have been found to harbor heterozygous or homozygous mutations in the ECM glycoprotein, Tenascin-XB [89, 97].”
InfluentialSakiyama, T., Kubo, A., Sasaki, T., Yamada, T., Yabe, N., Matsumoto, K., & Futei, Y. (2015) · The Journal of Dermatology · doi:10.1111/1346-8138.12829 · Cited by 32
Back to basics – how the evolution of the extracellular matrix underpinned vertebrate evolution
Huxley‐Jones, J., Pinney, J. W., Archer, J. P., Robertson, D. L., & Boot-Handford, R. (2009) · International Journal of Experimental Pathology · doi:10.1111/j.1365-2613.2008.00637.x · Cited by 29
“For example, Ehlers-Danlos syndrome, caused by defects in collagen processing, is associated with mutations in genes from the fibrillar collagen, tenascin, lysyl hydroxylase and ADAMTS gene families (Colige et al. 1999; Kuivaniemi et al. 1997; Yeowell & Walker 2000; Zweers et al. 2003).”
BackgroundLao, Q., Brookner, B., & Merke, D. P. (2019) · The Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2019.06.001 · Cited by 29
“The serum tenascin-X test based on enzyme-linked immunosorbent assay has been used to identify complete deficiency, but it is not accurate in identifying heterozygous forms and is not commercially available for general practice.(9,10) Nextgeneration sequencing often presents difficulties in mapping the RCCX module gen…”
BackgroundMethodEhlers-Danlos Syndrome, Hypermobility Type -- GeneReviews(®)
Ra, P., Adam, M. P., Hh, A., Se, W., Amemiya, A., Ljh, B., Bird, T. D., Ct, F., Mefford, H. C., Rjh, S., et al. (2016) · Europe PMC (PubMed Central) · Cited by 31
Ehlers-Danlos Syndrome: Immunologic contrasts and connective tissue comparisons
Islam, M., Chang, C., & Gershwin, M. E. (2020) · Journal of Translational Autoimmunity · doi:10.1016/j.jtauto.2020.100077 · Cited by 34
“In a minority of cases, however, variants in the TNXB and COL3A1 genes have been reported [1,45] and the condition is passed through via an autosomal dominant pattern.”
BackgroundMild Muscular Features in Tenascin-X Knockout Mice, A Model of Ehlers–Danlos Syndrome
Voermans, N. C., Verrijp, K., Eshuis, L., Balemans, M. C. M., Egging, D., Sterrenburg, E., van Rooij, I. A. L. M., van der Laak, J. A. W. M., Schalkwijk, J., M van der Maarel, S., et al. (2011) · Connective Tissue Research · doi:10.3109/03008207.2010.551616 · Cited by 29
Self-citationMoore, M. M., Votava, J. M., Orlow, S. J., & Schaffer, J. V. (2006) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2006.02.024 · Cited by 28
A connective tissue disorder may underlie ESSENCE problems in childhood
Baeza-Velasco, C., Grahame, R., & Bravo, J. F. (2017) · Research in Developmental Disabilities · doi:10.1016/j.ridd.2016.10.011 · Cited by 26
Tenascin-X—Discovery and Early Research
Miller, W. L. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.612497 · Cited by 26
“Among 20 obligate heterozygotes for a severely defective TNXB allele, 9 of 14 females but no males had hypermobility EDS (69).”
BackgroundEgging, D. F., van Vlijmen-Willems, I., Choi, J., Peeters, A. C. T. M., van Rens, D., Veit, G., Koch, M., Davis, E. C., & Schalkwijk, J. (2008) · Cell and Tissue Research · doi:10.1007/s00441-008-0591-y · Cited by 27
“…Medicine Cologne, Medical Faculty, University of Cologne, Cologne, Germany J. Schalkwijk (*) P.O. Box 9101, 6500 HB Nijmegen, The Netherlands e-mail: j.schalkwijk@derma.umcn.nl abnormal (Burch et al. 1997; Schalkwijk et al. 2001; Zweers et al. 2003; Peeters et al. 2004; Lindor and Bristow 2005).”
Self-citationEhlers-Danlos syndrome, classic type
Malfait, F., WENSTRUP, R. J., & Paepe, A. D. (2011) · Ghent University Academic Bibliography (Ghent University) · Cited by 27
The Genetics and Development of Scoliosis
Kusumi, K., & Dunwoodie, S. L. (2009) · Springer eBooks · doi:10.1007/978-1-4419-1406-4 · Cited by 29
Yoshizawa, T., Mizumoto, S., Takahashi, Y., Shimada, S., Sugahara, K., Nakayama, J., Takeda, S., Nomura, Y., Nitahara‐Kasahara, Y., Okada, T., et al. (2017) · Glycobiology · doi:10.1093/glycob/cwx099 · Cited by 27
Ehlers–Danlos syndrome – a commonly misunderstood group of conditions
Sobey, G. J. (2014) · Clinical Medicine · doi:10.7861/clinmedicine.14-4-432 · Cited by 30
Multiple Roles of Tenascins in Homeostasis and Pathophysiology of Aorta
Imanaka‐Yoshida, K., & Matsumoto, K. (2018) · Annals of Vascular Diseases · doi:10.3400/avd.ra.17-00118 · Cited by 22
Marino, R., Garrido, N. P., Ramirez, P., Notaristéfano, G., Moresco, A., Touzon, M. S., Vaiani, E., Finkielstain, G., Obregón, M. G., Balbi, V., et al. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab033 · Cited by 23
Glucocorticoid receptor polymorphisms in Korean patients with rheumatoid arthritis
Lee, E. B., Kim, J. Y., Lee, Y. J., & Song, Y. W. (2005) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2004.023432 · Cited by 23
Serum Tenascin-X Strongly Binds to Vascular Endothelial Growth Factor
Ishitsuka, T., Ikuta, T., Ariga, H., & Matsumoto, K. (2009) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.32.1004 · Cited by 22
Metadata
- Authors
- Zweers, M. C., Bristow, J., Steijlen, P. M., Dean, W. B., Hamel, B. C., Otero, M., Kucharekova, M., Boezeman, J. B., & Schalkwijk, J.
- Affiliations
- University of California, San Francisco (US)
- Corresponding author
- Zweers, Manon C.
- Venue
- The American Journal of Human Genetics
- Publisher
- Elsevier BV
- Published
- 2003-07
- Volume
- 73
- Issue
- 1
- Pages
- 214-217
- ISSN
- 0002-9297 (ISSN-L)
- PMC
- PMC1180584
- OpenAlex
- W2034854893
- Cited by
- 242
- References
- 16
- Citations by year
- 2026: 7 · 2025: 8 · 2024: 14 · 2023: 7 · 2022: 10 · 2021: 11 · 2020: 14 · 2019: 13 · 2018: 6 · 2017: 9 · 2016: 11 · 2015: 13 · 2014: 11 · 2013: 15 · 2012: 15
- FWCI
- 6.01
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 3671 d)
- Locations
- The American Journal of Human Genetics (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- Funders
- National Institutes of Health (5r01hl060875-03)
- National Heart, Lung, and Blood Institute (HL-60875)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Connective tissue disorders research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Dermatological and Skeletal Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Skin and Cellular Biology Research
- Keywords
- benign joint hypermobility syndrome, TNXB, haploinsufficiency, type XI collagen, COL11A1, COL11A2, COL3A1, connective tissue diseases, missense mutations, genotype-phenotype correlation
- MeSH terms
- Adult, Ehlers-Danlos Syndrome, Female, Haplotypes, Humans, Male, Middle Aged, Pedigree, Tenascin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.